wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37838448-02E7C0D5-A17E-4BE3-80FA-6C8FA5BC5E88
Q37838448-02E7C0D5-A17E-4BE3-80FA-6C8FA5BC5E88
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37838448-02E7C0D5-A17E-4BE3-80FA-6C8FA5BC5E88
Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma.
P2860
Q37838448-02E7C0D5-A17E-4BE3-80FA-6C8FA5BC5E88
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37838448-02E7C0D5-A17E-4BE3-80FA-6C8FA5BC5E88
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9ab5e2d7a58869b5cdea32607d91b936e458b869
P2860
Phase II trial of sorafenib plus interferon alfa-2b as first- or second-line therapy in patients with metastatic renal cell cancer.